AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to AbCellera's Full Year 2024 Business Update Conference Call. My name is Tamia [ph] and I will facilitate the audio portion of today's interactive broadcast.